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ABBREVATIONS 
 
AKI   –  Acute Kidney Injury 
CKD  –    Chronic Kidney Disease 
ESRD – End Stage Renal Disease 
ICU  – Intensive Care Unit 
RRT  – Renal Replacement Therapy 
ADQI – Acute Dialysis Quality Initiative 
GFR  – Glomerular Filtration Rate 
ARF  – Acute Renal Failure 
ACE  – Angiotensin Converting Enzyme 
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FeNa  – Fractional Excretion Of Sodium 
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AGE  – Acute Gastroenteritis 
LDH  – Lactate Dehydrogenase 
BUN  – Blood Urea Nitrogen 
 
 
                                               ABSTRACT
Background: Although  the  term  acute  renal  failure  was  replaced  by  acute
kidney injury (AKI) recently, there is a paucity of data on the incidence and
profile of AKI in hospitalized patienst from the developing world.
 AIMS AND OBJECTIVES: The objective of this study is to determine the
etiology, short term outcome and predictors of fatality in patients admitted to
thanjavur medical college hospital with AKI, aged more than 12 years.
Materials  and Methods: In this  prospective observational  study,  from April
2013 to October 2013, 100 patients admitted with AKI, defined according to the
AKI  Network  criteria.  The  patients  with  AKI  were  followed-up  until
discharge/death. Their clinical and biochemical data were studied.
Results : Among the 100 patients with acute kidney injury 56  male patients
and 44 female patients are included in the study. The common symptoms were
oliguria  ,  vomiting  ,diarrohea.the  common  etiologies  were  acute
gastroenteritis(28%),  snake  bite(20%),  septicemia(11%)  &  acute
glomerulonephriris  (  10%).conservative  treatment  was  done  in  45  %  of
patients  ,peritoneal  dialysis  & haemodialysis  done  in  55  % of  patients  and
overall mortality was 16 %.
Conclusion:  In our study ,  84%  of  patients  survived with 45 %of patients
treated  conservatively  and  improved  with  normal  renal  function.  30%  of
patients  underwent peritoneal  dialysis  and 26% underwent  haemodialysis.  In
our study mortality is 16% among 84% of survived 68% recovers with normal
renal function.
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INTRODUCTION 
Acute kidney injury 
(1)
 depicts the abrupt decline in renal function 
mostly occurs over the course (hours to days) and ends in retention of 
metabolic waste products and dysregulation of fluid, electrolytes, & acid 
base homeostasis. 
(1,2)
 
During the past decades acute loss of kidney function previously 
referred to as acute renal failure has been modified to acute kidney injury 
with increased recognition of importance of relatively small changes in renal 
function on both short & long term clinical outcomes. 
The kidneys being relatively unique among other organs of the body 
in its ability to recover from almost complete loss of function, AKI may 
develop in a wide variety of settings including ambulatory, outpatients, 
hospitalized, & particularly critically ill patients. AKI is associated with 
substantial morbidity and mortality
.(2) 
Although recovery of renal function occurs in majority of patients 
surviving an episode of AKI, many patients remain dialysis dependant or are 
left with severe renal impairment. More recently it has been recognized that 
even patients who have complete or near complete recovery of renal function 
are at increased risk of CKD and that superimposition of AKI on CKD is 
associated acceleration in the rate of progression to ESRD. 
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AKI complicates approximately 5-7% of hospital admission & 30% of 
admission to ICU patients. The risk of AKI is contributed by the acute insult 
and background morbidity. Acute insult  may be in the forms of sepsis and 
hypoperfusion, toxicity, obstruction, & parenchymal kidney disease. 
Background morbidities in the form of elderly, CKD, cardiac failure, liver 
failure, diabetes mellitus, vascular disease, nephrotoxic medication also 
contribute to insult. 
.(4) 
 
To prevent AKI: 4M   1. MONITOR PATIENTS 
                                     2. MAINTAIN CIRCULATION  
                                     3. MAINTAIN KIDNEY FUNCTION 
                                     4. MANAGE THE ACUTE ILLNESS. 
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AIMS AND OBJECTIVES 
 
Etiology and clinical presentation of acute kidney injury varies based 
on the endemicity of the area. Aim of the study is: 
 To prioritize the common etiologies of acute kidney injury in our 
hospital. 
 To assess the outcome of acute kidney injury in respect to its varied 
etiologies. 
 To predict the mortality  rate  of   acute kidney injury in our hospital 
during the study period. 
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                                        HISTORICAL REVIEW 
AKI is an ailment that has afflicted humans from time immemorial.  
WILLIAM BOWMAN (1816-1892) described bowman capsule and 
connection between glomerular capillary tuft and proximal tubules. 
In 1888 DALAFIELD describes microscopic pathology of AKI. In 
1917 during World War I AKI due to trauma reported as War Nephritis. 
 In 1941 LANDMARK ARTICLE by waters and brall in World War 
II in crush victims followed by impaired renal function and demonstrate 
widespread tubular damage and pigmented cast inside tubular lumen. 
In 1951 HORMER W SMITH introduced the term acute renal failure 
in his textbook ``THE KIDNEY STRUCTURE AND FUNCTION IN 
HEALTH SCIENCE 
5 
 In 1967 Silverstein Lee Henderson introduced hemodialysis.  In 1979 
kraner describes continous AV Hemodialysis. 
PHu in 2002 described sepsis induced AKI & advantage of 
hemofiltration  over automated peritoneal dialysis. 
 
 13 
The term acute renal failure has replaced by acute kidney injury in 
2004 as defined by RIFLE criteria .it also incorporates the entire spectrum of 
syndrome from minor change in kidney function to requirement of renal 
replacement therapy. 
HISTORICAL MILESTONES :- 
GALEN (EMPTY BLADDER) - (GREEK, ROMAN) 
 
 
MORGAGNI, 1760 (ISCHURIA RENALIS) - (18
TH
 CENTURY) 
 
 
BRIGHT, 1888 (ACUTE BRIGHT’S DISEASE) - (19TH CENTURY) 
 
 
DAVIES, 1917 ( WAR NEPHRITIS) - (20
TH
 CENTURY, BEFORE WORLD WAR ) 
 
 
BYWATERS AND BEALL, 1941 (CRUSH SYNDROME)- (20
TH
 CENTURY, AFTER 
WORLD WAR II) 
 
SMITH, 1951 (ARF) 
 
ADQI, 2004 (AKI) 
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DEFINITION AND STAGING OF AKI: 
It is defined by any one of the following (KDIGO) 
(1) 
Increase in serum creatinine by ≥0.3mg/dl (≥26.5µmol/l) within 48 
hours. 
Increase in serum creatinine to ≥1.5 time’s baseline which is known or 
presumed to have occurred within the previous seven days. 
Urine volume <0.5ml/kg/hr for more than six hours. 
 
(RIFLE AND AKIN CRITERIA) : 
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EPIDEMIOLOGY: 
The epidemiology of AKI is poorly characterized .The incidence 
depends upon précised population and definition of AKI. In 2001 AKI was 
diagnosed in 1.9% of hospitalized patients with RRT required in 7.5%of 
cases. Hospital mortality was 21.3% in patients who had AKI compared with 
2.5% in patients not identified as AKI. 
In a similar analysis during  1992-2001 with progressive increase 
incidence of AKI 11% per year over the 10 years studied -14.6 cases/1000 
discharges in 1992 to 36.4 cases/1000 discharges in 2001 Rate of AKI 
increased from 0.4% in 1998 to 2.1% in 2002 ; but the mortality decreased 
from 40.4% to 20.35. 
In multicenter trials 29,269 critically ill patients in 54 hospitals in 23 
countries the period prevalence of AKI was 5.7% with 72.5% 
(7)
 of these 
patients required RRT.ICU mortality rate has 52% with an additional 8% 
mortality in patients after ICU discharge. The overall mortality of 
60.3%.Among survivors 13.8% continues to require RRT at the time of 
hospital discharge. 
AKI is synonymous with the older term acute renal failure (ARF) and 
replacing the ARF in recent literature. The term AKI was introduced in the 
year 2004 by Acute Dialysis Quality Initiative (ADQI) 
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TYPES OF ACUTE KIDNEY INJURY  
Acute kidney injury is divided extensively in to three categories; they 
differ in pathophysiology and treatment. 
1. PRERENAL AZOTEMIA : represents functional response to renal  
Hypoperfusion 
(7)
 and it is not associated with structural renal injury. 
2. RENAL AZOTEMIA: diseases that directly involves renal 
parenchyma  (Intrinsic AKI). 
3. POST RENAL AZOTEMIA:  diseases associated with urinary tract 
obstruction. (Post renal AKI). 
 
CAUSES OF PRERENAL AKI: 
HYPOVOLEMIA: 
INCREASED EXTRACELLULAR FLUID LOSSES:  
Hemorrhage Gastrointestinal fluid loss: vomiting, diarrhea, Renal 
fluid loss: diuretics, osmotic diuresis, hypoadrenalism,  nephrogenic diabetes 
insipidus. 
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EXTRAVASCULAR SEQUESTRATION:  
Burns, pancreatitis, severe hypoalbuminemia (hypoproteinemia) 
 
DECREASED INTAKE: hypovolemia, altered mental status 
LOW CARDIAC OUTPUT STATE: 
Diseases of the myocardium or valves 
Pericardial diseases (including tamponade) 
Pulmonary hypertension 
Massive pulmonary embolism  
Impaired venous return (e.g.,abdominal compartment syndrome or 
positive pressure ventilation). 
 
SYSTEMIC VASODILATION: 
Sepsis 
Antihypertensive 
Anaphylaxis.  
 
RENAL VASOCONSTRICTION:  
Hypocalcaemia  
Catecholamine 
Calcineurin inhibitors 
Amphotericin B. 
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IMPAIRMENT OF RENAL AUTOREGULATORY RESPONSES: 
Cyclooxygenase Inhibitors, Angiotensin-Converting Enzyme 
Inhibitors Or Arbs, Hepatorenal Syndrome. 
 
PATHOPHYSIOLOGY: 
In prerenal AKI, restoration of normal renal perfusion results in early 
recovery of  Renal function .However sustained renal hypoperfusion 
(7) 
results in irreversible renal injury. Decreased renal perfusion or effective 
arterial blood volume depletion is described by activation of sympathetic 
nervous system and renin angiotensin System. 
Increased angiotensin II level constricts the postglomerular and 
preglomerular arteriole  and it is opposed by vasodilator prostaglandins, 
(9)  
the predominance of postglomerular vasoconstriction maintain 
intraglomerular capillary pressure to normal and maintains near normal 
GFR.  
Hemodynamic factors, increased levels of angiotensin II, activation of 
Sympathetic system will increase proximal tubular sodium and water 
reabsorbion.  
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Aldosterone and vasopressin secretion 
(10)
 will leads to increased 
sodium, urea and water reabsorbing in distal convoluted tubules .Thus 
physiological response  
leads to concentrated urine with decreased sodium concentration. 
In  patients with prerenal acute kidney injury the regulatory 
mechanism are unable to compensate fully for more severe degree of 
hypoperfusion it results in decline  in glomerular filtration rate. 
Autoregulation 
(11)
 is the first line defence of kidney against 
fluctuations of arterial blood pressure. When the renal perfusion decreases, 
the afferent arteriole senses the degree of stretch and thus relaxes. This is 
called  myogenic reflex. 
TUBULO-GLOMERULAR FEEDBACK also plays an important 
role in auto-regulation. Macula densa presenting in the cortical collecting 
ducts senses the decrease in solute delivery to the distal tubules and leads to 
afferent arteriole dilatation by releasing nitric oxide. 
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AUTOREGULATION 
                                           Decrease in renal perfusion 
                                           
     Renin, angiotensin II                                                   prostaglandins 
 
Increased efferent arteriole tone                     decreased afferent arteriole tone 
 
                                                     Maintained GFR                                         
            
Autoregulation and other intrinsic compensatory mechanisms fails 
once the systolic blood pressure falls below 80 mmhg .              
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FAILURE OF AUTOREGULATION 
                                    Decreased renal perfusion 
 
   Renin                                                                                Prostaglandins 
Angiotensin II              
                         
            ACE inhibitor                                            NSAIDs 
Decreased efferent arteriole tone                   increased afferent arteriole tone 
 
                                                      Reduced GFR 
The classic feautures are  
Low urine sodium concentration <20mmol/lit  
FeNa < 1% 
Low fractional excretion of urea <30% 
Increased urine osmolality. 
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CAUSES OF INTRINSIC ACUTE KIDNEY INJURY: 
RENOVASCULAR OBSTRUCTION : ( bilateral or unilateral in the 
setting of one kidney) 
Atherosclerotic plaque. 
Dissecting aneurysm 
Large vessel or small vasculitis.  
Thrombosis. 
Embolism. 
Obstruction of renal vein- thrombosis and compression. 
 
 
DISEASES OF THE GLOMERULAR VASCULATURE: 
Glomerulonephritis /vasculitis 
Disseminated intravascular coagulation 
Preeclampsia     
Thrombotic microangiopathy. 
Malignant hypertension. 
Collagen vascular diseases- systemic lupus erythematosus, 
scleroderma 
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ACUTE TUBULAR NECROSIS 
Ischemia- (12)         
 causes are the same as for prerenal ARF, but generally the effect is  
more severe and more prolonged. 
Toxins -EXOGENOUS  -   calcineurin inhibitors. 
Antibiotics –Aminoglycosides (18,19) 
 Radiocontrast 
(16)
 
Antifungals -Amphotericin B
(19) 
 Ethylene glycol 
Chemotherapy – cisplatin (20) 
 
  ENDOGENOUS-  rhabdomyolysis 
                                 hemolysis 
  
ACUTE INTERSTITIAL NEPHRITIS: 
Allergic: Antibiotics:βlactams,Sulfonamides,quinolones,rifampin. 
NSAID, Diuretics. 
Infection: Pyelonephritis -bilateral 
Infiltration: Lymphoma,Leukemia,Sarcoidosis. 
Inflammatory:   Sjögren’s syndrome. 
      Tubulointerstitial nephritis with uveitis. 
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Intratubular obstruction: Endogenous- Myeloma proteins, 
(21) 
Uric acid (tumor lysis syndrome),
(22)
 
Systemic oxalosis. 
                            Exogenous-Acyclovir, ganciclovir, methotrexate, indinavir. 
 
PATHOPHYSIOLOGY: 
Intrinsic AKI classified into Acute glomerular, interstitial and tubular  
injury. Correction of underlying cause does not result in complete recovery 
 
ACUTE TUBULAR NECROSIS: 
Acute tubular necrosis is the most common cause by the precipitating 
events such as ischemic and nephrotoxic process but frequently ATN is 
multifactorial such as acute illness with sepsis, hyponatremia, nephrotoxic 
drugs. 
(15 )
 Clinically ATN had intial oliguric phase within 24 hours of insult 
and last for 1-3 weeks followed by diuretic phase indicating renal recovery. 
Mortality rate is due to comorbid illness. 
The surviving patients recover kidney function but complete recovery 
may not  Occur. 
The urine sediment shows muddy brown granular cast. 
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Urinary sodium >40mmol/lit  
FeNa in excess of >30% 
Sloughing of cells, which is responsible for the formation of granular 
casts, is a feature of acute tubular necrosis. 
 
 
 
Photomicrograph of a renal biopsy specimen shows renal medulla, 
which is composed mainly of renal tubules. Patchy or diffuse denudation of 
the renal tubular cells with loss of brush border is observed, suggesting acute 
tubular necrosis as the cause of acute renal failure. 
 
 
 
 26 
 
ISHAEMIC ATN; 
(12)
 
Vasoconstriction. 
Desquamation of tubular  cells. 
Intraluminal tubular obstruction ends in tubular backleak. 
Local production of inflammatory mediators ends in interstial 
inflammation 
small vessel obstruction &local ischemia. 
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NEPHROTOXIC ATN: 
(17) 
 
SEPTIC ACUTE TUBULAR NECROSIS:
 (13,14)
 
Systemic and renal hypoperfusion
 
Endotoxins 
Activation of inflammatory mediators 
Microvascular endothelial damage. 
 
ACUTE INTERSTITIAL NEPHRITIS: 
Lymphocytic infiltration of interstitium.Clinically it presents as fever, 
rash, eosinophilia, eosinophiluria in only 10 to 30%.    
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Most common cause are NSAIDS, antibiotics, infection, malignancy 
and   systemic disease. 
Urine findings:  sterile pyuria, WBC casts, haematuria, Non nephrotic range 
proteinuria 
Diagnosis: renal biopsy. 
 
ACUTE GLOMERULONEPHRITIS: 
Acute glomerulonephritis and RPGN- Most common causes are post 
streptococcal  glomerulonephritis, endocarditis,  other infections. 
The pathology is related to damage to glomerular basement membrane 
and glomerular bleeding. 
Urine shows dysmorphic RBC, RBC casts are pathognomonic. 
Serology: complement assays, markers of hepatitis B, hepatitis C,  
Anti Streptococcal antibody, ANA, ANCA,  anti GBM antibody. 
Defnite: renal biopsy which shows proliferative changes in glomerulus 
and crescentic formation. 
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RADICONTRAST NEPHROPATHY: 
(16)
 
It is a rapid decline in renal function after radiocontrast administration. 
The serum  creatinine begins to rise 24 to 76 hours after contrast 
administration and peaks at 3 to 5 days  and return to baseline within 3 to 5 
days. 
 
Histopathology of AKI associated with toxins and venoms. 
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POSTRENAL AKI :
(22)
 
Post renal AKI results from obstruction of urinary collecting system 
 
CAUSES:  
UPPER TRACT OBSTRUCTION: 
Intrinsic:        Nephrolithiasis 
  Papillary necrosis 
    Blood clots  
  Transitional cell carcinoma 
Extrinsic:        Retroperitoneal or pelvic malignancy 
   Retroperitoneal adenopathy 
   Retroperitoneal fibrosis 
   Endometritis 
   Abdominal aortic aneurysm  
   Surgical injury 
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LOWER TRACT OBSTRUCTION: 
Bladder:  Neurogenic bladder 
 Transitional cell carcinoma  
  Blood clot 
  Bladder calculus 
  Prostate: prostate cancer 
  Benign prostate hypertrophy 
       Urethra:  Strictures,  Phimosis,  Urethral valves 
 
The pathophysiology of AKI leads to increased hydrostatic pressure in 
the renal Tubules leads to decreased glomerular filtration rate  .Inspite of 
effective advances in renal replacement therapy and Supportive measures, 
mortality rates in AKI exceed 50%.   
The poor prognostic factors of acute kidney injury are Age >65 years, 
Acute Respiratory failure, cardiac failure, Multi organ dysfunction               
syndrome. 
(23,24) 
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Groeneveld et al studied that 490 patients admitted to intensive 
medical care unit With AKI had mortality >60%.Gurucharan et al found 
that incidence of AKI is  Increased in burns and surgical ICU patients. 
(24)
  
 
 Nuraula et al found that 75 % Patients had medical cause for acute 
kidney injury, the most common being Septicemia, malaria, drugs, volume 
depletion, post transplant renal failure. 
 
SNAKE BITE INDUCED AKI: 
ACUTE KIDNEY INJURY complicates 5 to 30% of snake bite 
majority of snake bite induced acute kidney injury are due to viper bite. 
  WHO estimates that 1,25000 Death every year worldwide. In India it 
accounts for 10,000 deaths every year. 
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Snake bite induced AKI has diagnosed according to following criteria. 
Glomerular filtration rate rate of < 60 ml/m2 within 72 hours after 
snake bite. Glomerular filtration rate was estimated with Cockcroft gault 
equation.  
Snake bite induced AKI was increased in the following group of 
patients. 
Deranged haemostatic profile: 
An abnormal whole blood clotting time                               
Prothrombin time/activated partial thromboplastin time above 1.5 
times normal. 
 
BLOOD PARAMETERS: 
Created red blood cells in peripheral smear 
Increase in serum creatinine of> 30% of baseline 
Proteinuria 
Raised D dimer 
Low platelets < 1 lakh/m3. 
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HYPOTENSION AND ALTERD HAEMODYNAMICS: 
Haemarrhage 
Vasodilation 
Increased vascular permeability 
Direct or indirect cardiotoxicity 
 
PIGMENT NEPHROPATHY: 
Haemoglobinuria  after haemolysis 
Myoglobinuria after rhabdomyolysis. 
 
PATHOGENESIS OF ACUTE KIDNEY INJURY: 
More than 100 different kinds of peptides or proteins,lipids isolated 
from venom.  
Activation or inhibition of various coagulation proteins, endothelial 
disruption by phospholipase A2, serine protease, metalloproteinase and 
lectins leads to  cogulopathy.  
Haemarrhage leads to spontaneous bleed by directly injuring the 
vascular  endothelium. digestive hydrolases,hylaurinadase, and polypeptide 
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cytotoxin leads to local tissue necrosis. Permeability factors leads to 
increased extravasation of Plasma from intravascular smooth muscle leads to 
hypotension. 
GUPTA  et all., found that in 121 patients with snake bite 15 patients 
developed Acute kidney injury out of these 7 patients on conservative 
treatment and 8 needs  dialysis. 
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ACUTE GASTROENTERITIS INDUCED ACUTE KIDNEY INJURY: 
AKI due to AGE is common in adult and elderly people. Kidneys 
receive one fifth  of cardiac output .Due to severe diarrhea  loss of fluid and 
electrolytes leads to Renal hypoperfusion and also intense vasoconstriction 
during shock. tubular dysfunction also occurs due to shedding of epithelial 
cells. Most commonly Presents with oliguria, metabolic acidosis due to 
bicarbonate loss,  hypokalemia. 
MC histological lesion acute tubular necrosis. acute cortical necrosis 
also occurs. 
Mortality due to AKI is mainly due late referral, severe acidosis, 
anuria, metabolic Encephalopathy and mutiorgan failure. 
Chugh et all reported 63% of medical renal disease most commonly 
due to AGE the use of better sanitation, early treatment, decrease the 
incidence of post diarrheal acute kidney injury from 23% to less than 10% in 
the last 20 years. 
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ACUTE KIDNEY INJURY IN SEPSIS: 
Sepsis accounts for more than 40% of critically ill patients. In sepsis the 
Development of AKI is a higher predictor of mortality. Increase risk of 
AKI  
Mortality in patients with  age >65 years, hypertension, higher  APACHE 
Score, severe anemia, hyperphosphaetemia, hyperkalemia . 
In pregnancy common cause of AKI is septic abortion in early Pregnancy, 
puerperal sepsis in postpartum period. The pathogenesis is most  
Commonly due to ischemia, reperfusion injury, direct inflammatory 
injury, coagulation and endothelial  cell dysfunction and apoptosis. 
 
DRUG INDUCED AKI 
HIGH RISK COMBINATION FOR ACUTE KIDNEY INJURY: 
Volume depleted state: aminoglycosides 
Amphotericin B 
(19) 
Diuretics 
Haeme pigments 
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Preexisting renal disease or bilateral renal arterial disease: ACE 
inhibitors, Angiotensin receptor blockers , Hypertension, diabetes, 
elderly, congestive heart failure, jaundice: NSAID,Radiocontrast agents. 
FEVER INDUCED AKI: 
(27)
  
AKI is common in malaria. In endemic areas incidence of AKI >4 % 
mortality rates >45% in falciparum malaria.
(29)
 
The pathogenesis is impaired microcirculation due to parasitized red 
blood cells, Hypovolemia, disseminated intravascular coagulation, 
intravascular haemorrhage , jaundice. 
In a study panda sk et al., found that AKI had been associated with 20 
% of malaria. Renal failure was seen within 5 to 7 days from onset of fever. 
Other causes are leptospirosis, dengue, typhoid, and viral haemorrhagic 
fever. 
Most common cause of AKI in india : 
Diarrheal disease 
Sepsis 
Drug induced 
Hospital acquired 
Fever- malaria,  leptospirosis, viral hemorrhagic fever. 
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PATHOGENESIS OF ACUTE KIDNEY INJURY: 
 
The pathogenesis of AKI is complex involving renal injury and repair. 
Kidneys are susceptible to ischemia and toxins leads to 
vasoconstriction, endothelial damage and activation of inflammatory 
process. Inflammation results. 
 
In reduction in local blood flow to the outer medulla with alteration in 
tubule  function and viability. 
 
With ischemia & reperfusion, endothelial cells express a number of 
adhesions Molecules which are counter receptors on leucocytes. Numerous 
vasoactive. Mediators that are released with injury such as nitric oxide may 
also affect leucocytes  endothelial interactions. 
 
There is obstruction of the microvascular as well as enhanced 
vasoconstriction tubules generate proinflammatory and chemotactic 
cytokines. 
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 Injection of stromal cells is protective against renal injury which is 
assessed by serum creatinine measured  24 hours after ischemia. It is thought 
it is due to intra renal paracrine effects to decrease inflammation or by 
systemic immune modulation. The epithelial cells which replace the lost 
cells derive from surviving tubular epithelial cells. 
 
CLINICAL COURSE OF ACUTE KIDNEY INJURY: 
(1,2) 
The course of AKI is characterized by three phases 
 
INITIATION PHASE (HOURS TO DAYS) 
Initial period of renal hypoperfusion during which ischemic injury is 
evolving. 
GFR decline because of decrease in glomerular ultrafiltration rate, 
presence of glomerular filtrate within tubules. and backleak of glomerular 
filtrate through injured tubular epithelium. This phase lasts for hours to days.  
 41 
Restoration of renal perfusion or elimination of nephrotoxin may 
recover or limit the kidney injury. 
 
MAINTANENCE PHASE: 
The phase lasts for one to two weeks during which renal injury is 
established . GFR stabilizes at nadir (5 to 10 ml/min).urine output will be 
very low.  
Uremic complications will appear in this phase. 
 
RECOVERY PHASE: 
Characterized by repair and regeneration of renal parenchymal cell 
particularly tubule epithelial cell and gradual return of  glomerular filtration 
rate. The recovery phase may be complicated by diuretic phase owing to 
marked excretion of retained salt and water. 
Sodium handling and concentration functions are the last function to 
recover particularly in elderly. In general recovery of renal function is less 
complete in older patients than young. 
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PROGNOSIS: 
(3) 
The prognosis of acute kidney injury depends upon causes and 
severity of disease. Overall prognosis in acute kidney injury is poor. 
Morbidity depends upon severity of injury and underlying disease .Patients 
requiring dialysis is at higher risk. 
Factors influencing patient survival in acute kidney injury: 
Etiology of acute kidney injury 
Severity of AKI as evidenced by oliguria, maximal serum creatinine 
and need for RRT 
Number and severity of coexistent illness. 
Age 
Complications 
Infection-sepsis, pulmonary infection,  hypercatabolism. 
Non infectious causes - heart failure, respiratory failure, 
gastrointestinal disease, advanced liver disease, pancreatitis and burns. 
Several studies have identified that age has an adverse prognostic 
factors in acute kidney injury. Age more than 60 years has poor 
prognostic indices than younger patients. However studies have shown 
 43 
that sex has no predicting value. Among the medical cause AKI 
induced by aminoglycosides, nephrotoxic agents have good prognosis 
and acute kidney injury following sepsis has poor prognosis.AKI due 
to medical causes has better prognosis than surgical causes.  
kaufmon et al found that despite a rapid reversal of AKI in prerenal 
and postrenal patients ,mortality is still high probably because of 
coexisting diseases like shock , acute and chronic cardiac disease, 
respiratory failure, mechanical ventilation , pneumonia, chronic lung 
disease .Vascular diseases have poor outcome in acute kidney injury. 
Overall oliguric AKI has a worse prognosis. 
CLINICAL FEAUTURES OF ACUTE KIDNEY INJURY:
(1)
 
The common symptoms are: 
Oliguria- urine output less than 400ml/day 
Anuria 
Convulsion 
Breathlessness 
Obstructive urinary symptoms 
Nausea and vomiting 
Weakness 
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Physical signs: 
PRE RENAL AKI:  
 Volume depletion- absolute or postural hypotension 
 Low jugular venous pressure 
 Dry mucous membrane 
 Decreased effective circulatory volume- heart failure 
                                                                Hepatic failure  
RENAL AKI: 
     Renal artery thrombosis- flank or abdominal pain 
   Atheroembolic disease- retinal plaques, palpable purpura, livedio 
reticularis. 
Renal vein thrombosis- history of nephritic syndrome or pulmonary 
embolism. 
Disease of small vessel & glomeruli- new cardiac murmur 
(postinfectious)     skin rashes/ ulcers(lupus) Sinusitis (anti GBM disease) 
Lung haemorrhage (anti   GBM , ANCA, lupus) 
Haemolytic uraemic syndrome - fever, neurologic abnormalities. 
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Malignant hypertension - evidence of end organ damage such as 
headache, blurring of vision .heart failure, left ventricular hypertrophy. 
Ischemia- recent hemorrhage or hypotension. 
Exogenous toxins - recent exposure to  nephrotoxic antibiotics or 
chemotherapy in  coalition with sepsis or volume depletion. Exposure to 
radiocontrast in association with volume depletion, chronic kidney disease, 
diabetes. 
Endogenous toxins- rhabdomyolysis ( trauma, immobilization, post 
ictal state) haemolysis  (fever or evidence of blood transfusion) 
Tumour lysis- chemotheraphy 
Multiple myeloma- age more than 60 years, fatigue, malaise, 
lowbackache. 
Ethylene glycol – alcohol abuse, altered  mental status. 
Disease of tubulointerstitium- fever, rash, arthralgia. 
POSTRENAL AKI: 
(30,31) 
Increased urinary urgency, frequency, dysuria &dribbling 
Recurrent urinary tract infection or renal calculi 
Acute onset of anuria and polyuria 
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Prostate ,intraabdominal, cervical , retroperitonel or pelvic tumours. 
Previous radiation therapy to abdomen 
History of vaginal bleeding, subtotal hysterectomy. 
LABORRATORY INDICATORS : 
(32) 
Haemoglobin, complete blood count, erythrocyte sedimentation rate. 
Blood urea, serum creatinine, serum electrolytes. 
Serum albumin,  total protein. 
Liver function tests. Peripheral smear. 
Diagnostic indices: 
Prerenal AKI - high BUN /serum cretinine >20:1 is suggestive. 
Elevated LDH - renal artery thrombosis. 
Eosinphilia, hypocomplement - atheroembolic disease. 
Small vessel vasculitis – ANA , ANCA,anti GBM antibody,hepatitis 
serology, blood culture,complement. 
Haemolytic uraemic syndrome  - schistocytes on peripheral smear, 
increased LDH, anaemia, thrombocytopenia. 
Rhabdomyolysis – increased myoglobin & creatine kinase. 
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Haemolysis – pink plasma, increased LDH. 
Tumour lysis  - hyperurecemia, hypocalcemia, increased LDH. 
Multiple myeloma – circulating monoclonal spikes, anaemia. 
Ethylene glycol ingestion – high anion metabolic acidosis. 
 
URINARY INDICES IN ACUTE KIDNEY INJURY: 
PRERENAL AKI:     
                  hyaline casts 
                   FENa < 1% 
                   Urine sodium < 10 mmol/lit 
                   Specific gravity  > 1.018 
                   Urine urea nitrogen / plasma urea nitrogen > 8. 
                  Urine cretinine / plasma creatinine >40. 
                  Urine osmolality  >500. 
                   Renal failure index  < 1. 
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INTRINSIC AKI: 
Acute tubular necrosis – muddy brown or tubular epithelial casts 
                                        FENa >3 % 
                                        Urine sodium > 40 mmol/lit 
                                        Specific gravity-1.010 
                                        Fractional excretion of urea - < 60 %  
Acute interstitial nephritis – white blood cell cast 
                                               FENa > 1% 
                                               Haematuria 
                                               Eosinophilluria. 
Acute glomerulonephritis –urine sodium < 20 mmol/lit 
                                             FENa < 1 %. 
                                             Dysmorphic red blood cells / RBC casts. 
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 The following table shows some differentiating features between AKI 
and CKD 
 
 
 
 
FEATURE AKI CKD 
Antecedent history of renal disease Absent Present 
Prior sustained elevation of 
Creatinine for > 3 months 
Absent Present 
Anaemia Usually absent at onset Present 
Elevated serum phosporous,         
PTH. 
Decreased serum calcium 
Absent ( in early 
phase) 
Present 
Neuropathy Absent Present 
Band keratopathy Absent Present 
Renal bone disease Absent Present 
Small kidneys on USG Absent Presen 
Tolerance to azotemia, acidosis Absent Present 
Stability of azotemia Absent(daily rise) Present 
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WBC CAST: 
 
 
GRANULAR CAST: 
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RBC CAST: 
 
 
 
 DYSMORPHIC RBC             
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IMAGING PROCEDURES IN THE DIAGNOSIS OF ACUTE 
KIDNEY INJURY: 
Ultrasonography :To assess the kidney size, calculi, hydronephrosis, renal 
or retroperitoneal mass. 
Intravenous urography: for assessing kidney size,function , 
hydronephrosis, hydroureter , bladder size ,bladder outlet obstruction . 
Radionucleotide scans : for assessing blood flow & function,gallium 67 
scan for acute interstitial nephritis. 
Renal biopsy : 
Indications : acute kidney injury of unknown etiology 
AKI associated with glomeulonephritis, nephrotic syndrome, or vasculitis 
where acute theraphy is contempted. 
AKI with interstitial disease without a definite etiology. 
Prolonged acute kidney injury for more than 28 days 
AKI associated with systemic disease : SLE, wegners granulomatosis 
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MARKERS OF KIDNEY FUNCTION:- 
At present there is no single marker valid that can predict the renal 
function. Serum creatinine and BUN are commonly used to estimate the 
renal function. 
UREA AND UREA CLEARANCE 
Urea elimination by kidney is a complex process. Hence BUN is a less 
useful marker of kidney function plasma level of urea is impacted by many 
factors other than GFR . Non renal causes for exalted  BUN level are GIT 
bleeding, steroid use, total parenteral nutrition. Also malnutrition, chronic 
liver disease can cause decrease in BUN level due to reduced production.  
CREATININE AS A MARKER FOR KIDNEY FUNCTION:- 
Creatinine is a metabolic product of creatine and the major sources are 
skeletal muscles, dietary meat. Daily production of creatinine ranges from 20 
to 25 mg / kg / day in males and 15 to 20 mg / kg /day in females. 
Creatinine is removed by both glomerular filtration and proximal 
tubular secretion. In healthy individuals, >90% of creatinine removal is by 
glomerular filtration and the rest is by tubular secretion. But when renal 
function starts decreasing, the proportion of creatinine which is eliminated 
by tubular secretion increases up to 50%. (38)
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Glomerular filtration rate (GFR): 
GFR is defined as the sum of the filtration rate of all functional 
nephrons. The normal value is around 125 ml/min/1.73m
2 
for men and 100 
ml/min/1.73m
2
 for women. GFR is measured by the following formula, 
                               GFR =   U * V / P. 
              Where,     U is the concentration of the substance in urine 
                               P is the concentration of the substance in plasma 
                               V is urine flow rate. 
The substrate used should be biologically inert, freely and completely 
filtered by the glomeruli, neither secreted nor absorbed by tubules, and not 
degraded by the kidneys. 
Inulin was once measured gold standard of exogenously administered 
markers of GFR. But, a number of factors like scarcity, high cost, problems 
related to urine collection to determine inulin clearance limits the usefulness 
of inulin as a marker of GFR. Creatinine is routinely used to calculate GFR. 
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Estimation of creatinine clearance & GFR by creatinine based 
equations: 
Cock croft- gault formula, modification of diet in renal disease study 
(MDRD) equation are the two widely used creatinine based equations for the 
estimation of GFR in adult. 
 COCKCROFT – GAULT EQUATION(39): 
            Est. creatinine clearance = (140 – age ) × body weight ×0.85 (if female) 
                                                                 72 × plasma creatinine 
 MDRD EQUATION : 
Est. GFR = 170 × (PCr)
-0.999
 × (age)
-0.175 
× (0.762 if female) × (1.180 if 
African American) × (BUN)
-0.170 
× (albumin)
+0.318
. 
Cockcroft- gault and MDRD equations are important as they can 
underestimate GFR with normal renal function and overestimate GFR with 
severe renal dysfunction. 
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LIMITATIONS OF CREATINIE AS A MARKER FOR GFR: 
Creatinine based GFR equations tend to over estimate renal function. 
so, when using creatinine to assess renal function the following limitations 
should be considered. 
1) Creatinine production relay upon certain factors of a patient like 
body mass, race, age etc… 
2) The change in plasma creatinine does not correlate with decline 
in renal function in a linear fashion. 
3) The changes in creatinine in an individual should be interpreted 
based on the baseline creatinine value. For this a base line 
normal value is essential which is not available in most cases. 
4) Creatinine level can also be altered by substances that interfere 
with the tubular secretion of creatinine. For example, drugs like 
trimethoprim, cimetidine blocks tubular secretion and hence can 
increase creatinine level. 
5) Creatinine is a useful marker of GFR in the steady state only. In 
acute kidney injury it does not correlate with the sudden 
changes in GFR. 
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So, changes in serum creatinine level lag several days behind actual 
changes in GFR. Also the alterations in the level of serum creatinine for 
small changes in GFR are not so sensitive or specific. Hence many other low 
molecular weight serum proteins have been investigated as suitable 
endogenous markers of GFR 
DETERMINANTS OF SERUM LEVEL OF CREATININE:                
                                            PRODUCTION (P) 
                                                 (cells, tissues) 
                                                                 
                                                Serum level (S)                  
 
                       
                                         Extra renal elimination 
                                                  ( GIT, liver) 
Where U × V denotes renal excretion. 
(ie) the serum levels are determined by the interaction between production, 
excretion of creatinine. 
Production (P)      
(diet) 
9 
  
U × V (kidney) 
GFR 
TS 
 58 
BIOLOGICAL MARKERS OF ACUTE KIDNEY INJURY: 
An abrupt change in serum creatinine , the most common indicator of 
AKI is strongly associated with poor outcome across multiple clinical 
trials.AKI presents as array of derangements by underlying precipitant, 
variable anatomical site of involvement, metabolic complication of 
unregulated inflammation , oxidative stress and insulin resistance. 
The newly proposed markers such as urine IL 18,NGAL, L–FABP,  
KIM-1 , π-GST ,NAG and cystatin C differentiate between established AKI 
and control patients without acute elevation serum creatinine. 
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URINE CYSTATIN C: 
Reabsorbed through megalin receptor in proximal tubules 
Poor AKI predictor 
Sepsis per se increase urine cystatin levels due to competitive 
inhibition of megalin receptor due to increased urine albumin in sepsis, 
KIDNEY INJURY MOLECULE (KIM -1) 
(49) 
Transmembrane glycoprotein expressed on epithelial cells after injury  
Involved in the cellular repair process 
Moderate ability to predict acute kidney injury 
INTERLEUKIN 18: 
(51) 
It is a pro-inflammatory cytokine secreted by the proximal tubular 
cells and leucocytes  
Varying ability to predict AKI . 
N-ACETYL  β-d – GLUCOSAMINIDASE (NAG): 
It is a lysosomal enzyme found in several human cells including 
tubular epithelial cells > 130 dalton not fitered , elevated urine levels 
in several acute renal diseases  
Moderate ability to predict AKI.  
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URINARY LIVER TYPE FATTY ACID BINDING PROTEIN                   
(L-FABP) 
It is a fatty acid binding protein , molecular weight of approximately 
14 Kda, distributed confined to the proximal tubular epithelial cells.  
In healthy human kidney, LFABP is reportedly found in the cytoplasm 
of proximal tubular epithelial cells and is rapidly released in to the tubular 
lumen in response to ischemia and oxidative stress. 
NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN: 
(NGAL)
(50) 
Involved in iron transport , released by neutrophils upon activation  
Increased expression in several tissue in response to inflammation  
Among the most up regulated genes in tubular cells after ischemic 
AKI in animal model. 
Other markers: 
Alanine aminopeptidase 
Alkaline phosphatase 
α-Glutathione -S- transferase 
β2microglobulin 
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α 1microglobulin 
Retinol binding  protein  
Microalbumin  
Clusterin  
Cysteine rich protein  
Osteopontin , exosomal fetulin –A . 
Haptogloin,haeme oxygenase,fibulin 1. 
Vanin – 1- drug induced AKI 
MANAGEMENT OF ACUTE KIDNEY INJURY 
Prevention: 
(53) 
In ischemic and nephrotoxic AKI ,there are no specific treatment 
modalities available, prevention is of paramount importance .Many patients 
with ischemic AKI can be prevented by attention to cardiovascular function 
and intravascular volume in high risk patients such as elderly and with 
preexisting CKD patients. 
In case of ischemic AKI due to major surgery ,trauma, burns, cholera, 
aggressive restoration of intravascular volume decline the incidence of 
AKI.
(43) 
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The incidence of nephrotoxic AKI can be declined by altering the dose and 
frequency of nephrotoxic drugs to body and glomerular filtration rate. Serum 
creatinine is an insensitive indicator of GFR and overestimates GFR in 
elderly and young patients. Adjusting drug dosage according to 
bioavailablity of drugs appear to decline kidney injury.
(40)
 
The drugs such as diuretics, NSAIDS,ACE inhibitors, angiotensin 
receptor blockers,should be used caution with suspected  true or effective 
hypovolemia or renovascular disease , they may precipitate ischemic AKI. 
Allopurinol and forced alkaline diuresis are useful prophylactic measures to 
prevent precipitation of uric acid crystals in renal tubules in patients at high 
risk for acute urate nephropathy ( cancer chemotheraphy in haematological 
malignancy). 
N acetyl cystine 
(43)
  limits acetaminophen induced kidney injury 
&should be given within 24 hours of ingestion.in radiocontrast nephropathy 
(45)
 hydration is an effective preventive approach ,volume expansion with 
bicarbonate containing IV fluids are superior to normal saline administration. 
Specific treatment: 
(41)
 
      Prerenal AKI is reversible upon correction of haemodynamic 
abnormality &post renal AKI resolves upon relief of obstruction. 
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PRERENAL AKI: 
According to the type of fluid in hypovolemia the replacement fluid 
can be tailored. In case of moderate haemarrhage or plasma loss (burns or 
pancreatitis) isotonic saline can be used, in severe hypovolemia due to 
haemarrhage corrected with packed red blood cells. 
(67,68) 
In case of urinary and gastrointestinal fluid loss hypotonic fluid are 
usually recommended , serum potassium &acid base must be monitored 
carefully and potassium,bicarbonate supplement should be given. 
In case of cardiac failure  Inotrophic  agents, preload and afterload 
reducing agents ,mechanical ventilation such as intraaortic ballon pump.  
In case of cirrhosis with ascitis fluid management is difficult, 
reversible AKI due true  or effective hypovolemia must be distinguished 
from hepatorenal syndrome . 
The contribution of  hypovolemia due to AKI are assesed only by 
administration of fluid challenge tests
(52)
. Fluid administered slowly based  
on JVP, CVP and  PCWP. Incase of refractory ascitis transjugular 
intrahepatic portosystemic shunt improve renal function by increased central 
volume and suppression of aldosterone and noradrenaline secration. 
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INTRINSIC AKI: 
            To attenuate injury or hasten recovery in ischemic & nephrotoxic 
AKI has been tried, some of them are ANP, low dose dopamine , endothelial 
antagonists , loop diuretic , calcium channel blockers, prostaglandin 
analogues, antioxidants, antibodies against leucocyte adhesion molecules, 
and IGF type1.  
AKI due to other intrinsic renal disease such as acute glomeronephritis or 
vasculitis  to steroids and immunosuppressive agents. Aggressive control of 
blood pressure is particularly important in malignant hypertension . 
POSTRENAL AKI:  
Obstruction of urethra or bladder neck is initially managed by 
transurethral or suprapubic bladder catheter.uretric obstruction managed 
initially by percutaneous cathetrisation of dilated renal pelvis or ureter. 
PERITONEAL DIALYSIS : 
(54) 
Peritoneal dialysis involves the transport of solutes and water across 
the membrane that  seperates two fluid containing compartments- Blood in 
the peritoneal capillaries in renal failure contains excess of urea, creatinine,& 
other solutes: Dialysis solution in the peritoneal cavity which contains 
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sodium , chloride and lactate or bicarbonate & it is rendered hyperosmolar 
by the inclusion of a high concentration of glucose . 
Physiology of peritoneal transport : 
Diffusion : Uraemic solutes and potassium diffused from peritoneal capillary 
blood into the peritoneal dialysis solution where as glucose, lactate, calcium 
& bicarbonate in the opposite direction . 
Diffusion depends upon  
Concentration gradient. 
Effective peritoneal surface area. 
Molecular weight of solute concerned . 
Ultrafiltration : 
It results as a consequence of the osmotic gradient between the 
hypertonic dialysis solution and the relatively hypotonic peritoneal capillary 
blood .it depends upon  
Concentration gradient for osmotic agent (eg:glucose). 
Hydraulic conductance of peritoneal membranes . 
Hydrostatic pressure gradient . 
Oncotic pressure gradient. 
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Sieving. 
Reflection coefficient for osmotic agents. 
Effective peritoneal surface area. 
Fluid absorption:  
Intraperitoneal hydrostatic pressure  
Effectiveness of lymphatics 
Disadvantages of peritoneal dialysis: 
Less efficient than haemoperfusion in treatment of acute kidney injury 
for flash pulmonary edema,poison or drug overdosage, acidosis 
,hyperkalemia. Moderate protein could complicate mal nourished ,critically 
ill patients. However mortality due peritoneal dialysis and haemoperfusion 
are similar. 
Contraindications : 
(55) 
Absolute – recent surgery requiring abdominal drains  
                 Pleuroperitoneal fistula 
Relative contraindication – severe hypercatobolic state –decreased clearance 
                                             Abdominal wall cellulitis  
                                             Adynamic ileus 
                                             New aortic prosthesis 
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Dialysis solution: 
 Dextrose  – 1.5grams/dl to 4.25 gms/dl 
Osmolarity – 346mosm to 485 mosm 
Ultrafiltration – 50-150 ml/exchange 
Complication of peritoneal dialysis: 
Peritonitis 
Abdominal distension  
Hypotension 
Hypernatremia 
Hyperglycemia 
Hypoalbuminemia. 
HAEMODIALYSIS: 
(56) 
The blood is passed through an extracorporeal circulation where it is 
separated from the dialysis fluid by an artificial semipermeable membrane. 
water molecules and low molecular solutes in the two solution can pass 
through membrane pores and intermingle but large molecules such as 
proteins cannot pass.  
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Temporary access is established by the percutaneous insertion of 
catheter into a large vein (internal jugular vein, femoral , less commonly 
subclavian ). venous catheters are commonly used for autocoagulation in 
case of acute kidney injury. 
INSERTION LOCATION : 
The optimal insertion site is right internal jugular vein. femoral vein 
cathetrization is a good choice when need for haemoperfusion is expected to 
less than one week. Subclavian site avoided - pneumothorax,subclavian 
artery perforation , brachial plexus injury. 
COMPLICATIONS : 
Immediate – arterial puncture              
Pneumothorax                  
Haemothorax           
Arrhythmias                                   
Air embolism            
Perforation of vein or cardiac chamber          
Pericardial tamponade 
Delayed -Thrombosis         
       Infection         
 Vascular strictureAV fistula       
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  Injury to adjacent structure – brachial plexus injury Trachea 
Recurrent laryngeal nerve. 
HAEMODIALYSIS PRESCRIPTION : 
(57,58) 
Reduce the amount of dialysis for the initial one or two session , if 
predialysis blood urea nitrogen > 125 mg/dl dialysis session length reduced 
to two hour at a time & blood flow rate 250ml/min. 
Longer initial dialysis session and increased blood flow rate results in 
disequilibrium syndrome, length of second session increased to 3 hours if the 
predialysis BUN < 100mg /dl . A typical 3 to 4 hours acute dialysis session 
will deliver a single pool Kt/v of only 0.9 with a equilibrated kt/v of  0.7 
dialysate side urea removal may be even lower ( evan et al -1999) 
  Data by schiffl et al -2002 found that mortality is reduced in patients 
with AKI dialysed six times per week as opposed to those receving every 
alternate day. 
Dialyzer membrane:  
Unsubsituted cellulose membrane had a lower pulmonary diffusion 
capacity- Heerero et al -2002                    
Subramanian et al 2006 – unsubsituted cellulose should not be used 
for acute dialysis 
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Dialysis solution (variable) 
Base bicarbonate -145Mm       
 Potassium – 3.5mM        
 Calcium – 3.5mEq/L       
 Magnesium – 0.75mEq/L       
 Dextrose -200mg/dl       
 Phosphate –none 
COMPLICATION DURING HAEMOPERFUSION: 
Hypotension: 
     Volume related -high ultra filtration rate, Low dialysis sodium 
     Inadequate vasoconstriction – High dialysis solution temperature  
                                                     Autonomic neuropathy 
                                                     Antihypertensive medication  
                                                     Eating during treatment 
                                                     Anaemia 
                                                    Acetate buffer 
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Cardiac factors – diastolic dysfunction ,       
      Arrhythmias        
      Ischemia       
Myocardial infarction     
Pericardial tamponade 
      Septicemia 
    Hemolysis 
           Air embolism 
Muscle cramps –Hypotension , hypovolemia, high ultrafiltration rate , 
use of low sodium dialyzate solution. 
Headache, Chest pain /back pain, Itching, Fevers /chills, Dialyzer 
reaction Arrhythmias, Cardiac tamponade, Intracranial bleeding Seizures, 
Haemolysis, Air embolism. 
Visual & hearing loss – Evans et al found that transient blindness in 
patients with glaucoma and hearing loss due to endolymphatic hydrops. 
Dialysis associated neutopenia & hypoxemia 
Disequilibrium syndrome – systemic and neurologic symptoms associated 
with characteristic EEG abnormality. 
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Clinically- nausea, vomiting, restlessness , headache, seizures, 
obtundation  & coma. 
Etiology – acute increase in brain water content due to plasma solute 
level is rapidly lowered during  dialysis , the plasma become hypotonic with 
respect to brain cells  & water shift from plasma in to brain tissue. 
Nutrition and life style changes in AKI patients: 
Protein -1.2 g of proteins /kg daily-atleast 50 % of proteins had high 
biological  value. Rocco et al in 2004 : 30 – 50 % of heamoperfusion patients 
intake of less than 1.0g/kg body weight per day. 
Energy – less than 61 years -35 kcal/ kg/ day 
                More than 61 years 30 -35kcal /kg /day 
In HEMO study intake based on dietary recall average is 23 – 
27kcal /kg /day 
Carbohydrates – 50 to 60 % of dietary intake which represents 1000 kcal or 
250 grams of carbohydrate for a 2000 kcal diet. 
Lipids – LDL cholesterol < 100 mg /dl 
             Fasting triglycerides  - < 500 mg /dl 
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Therapeutic life style change : 
Diet  
Weight reduction 
Increased physical activity  
Abstinence from alcohol 
Treat hypoglycemia. 
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MATERIALS & METHODS 
INCLUSION CRITERIA: 
All inpatients  with  clinical and / or biochemical evidence of acute   
kidney injury. 
EXCLUSION CRITERIA: 
 Patients with diabetes mellitus 
 Patients with CKD 
 Patients aged below 12 years. 
METHODOLOGY: 
Patients at risk of developing AKI (ie)   history of preceding snake 
bite, ADD, febrile illness, septicemia, poisoning with symptoms suggestive 
of AKI were selected. Patients having one or more risk factors for CKD and 
patients already having CKD are excluded.  
Patients social, demographic, economic and medical details were 
recorded in the proforma sheet. Also the history regarding the symptoms of 
AKI like decrease in urine output was recorded and the duration of 
symptoms (in hours) was also recorded. Base line clinical examination of 
patient was done. Vitals were recorded. Baseline investigations done. USG 
abdomen was done for all patients to assess the renal size and texture to rule 
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out CKD.other relevant investigation such as ANA,renal biopsy, fever 
profile was done. 
        The day the AKI criteria was fulfilled according to serum creatinine 
was noted as day -I. We used either the rise in serum creatinine of ≥ 0.3 
mg/dl or ≥ 150 to 200 % from baseline to diagnose AKI.  
Also the duration of stay in hospital is noted for all patients and the 
number of dialysis needed for those who developed AKI was also 
recorded.the outcome was compared with  the cause, clinical and 
biochemical parameters. 
Statistical analysis 
We calculated the mean  ±  standard deviations (x ± s) or the medians 
for continuous variables and proportion of categorical variables. T-test was 
used to compare the continuous variables of normal distributions. Rank sum 
test was utilised for the continuous variables with abnormal distributions. 
Chi-square test was employed to compare categorical variable data. P   value 
< 0.05 was considered significant. Data were analysed using SPSS11.5 
software.  
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OBSERVATION & RESULTS 
 
TABLE.1  GENDER DISTRIBUTION 
 
 
 
 
 
 
Males and female gender distribution in my study was almost equal 
with a slight predominance to male gender. 
Sex difference doesn’t show any significant difference in the outcome 
                                                                 
SEX 
No.of patients 
(n=100) 
Percentage 
(%) 
Male 56 56.0 
Female 44 44.0 
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TABLE.2  AGE DISTRIBUTION 
                
                 
 
 
 
 
 
          
 
In our study group majority of them fall with in age limit of  below 25 
years even after excluding those below 12 yrs. Mean age group in my study 
was 42.6 years. 
 
Age in years 
No of patients 
(N=100) 
Percentage 
% 
Below 25yrs 21 21.0 
26 to 35yrs 15 15.0 
36 to 45yrs 19 19.0 
46 to 55yrs 20 20.0 
56 to 65yrs 19 19.0 
66yrs & above 6 6.0 
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TABLE.3  CLINICAL SYMPTOMATALOGY 
 
CLINICAL SYMPTOMATALOGY
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This graphical representation shows varied clinical presentation of 
AKI. almost 70% of them had decreased urine output as a significant 
complaint.  
In our part of the country loose stools (diarohea) also contributes to 
major part of AKI. 
Signs 
&symptoms 
No.of patients 
(n=100) 
Percentage 
(%) 
Oliguria 69 69.0 
Vomiting 28 28.0 
Loose stools 28 28.0 
Oedema 13 13.0 
Jaundice 13 13.0 
Fever 05 05.0 
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TABLE.4  CAUSES OF ACUTE KIDNEY INJURY 
 
This table represents various causes of acute kidney injury in our 
patients. 
 
          Diagnosis  
No.of patients 
(n=100) 
Percentage 
(%) 
AGE 28 28.0 
Bite 20 20.0 
Septicemia 11 11.0 
Mods 4 4.0 
Fever 5 5.0 
Poison 8 8.0 
Glomerulonephritas 10 10.0 
Drug induced 3 3.0 
Boo/BPH 5 5.0 
Ca cervix / Ca cervix RT 4 4.0 
Renal calculi 2 2.0 
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TABLE.5  TYPE OF RENAL FAILURE 
 
 
 
 
 
   
 
As mentioned in various literature in my study also intrinsic type of 
renal failure consititutes a major type of acute kidney injury.  
 
Type of renal 
failure 
No.of patients 
(n=100) 
Percentage 
(%) 
Post Renal 11 11.0 
Pre Renal 28 28.0 
Renal 61 61.0 
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TABLE.6  UREA LEVELS 
UREA LEVELS 
No.of patients 
(n=100) 
Percentage 
(%) 
Less than 100 37 37.0 
101 to 150 34 34.0 
151 to 200 21 21.0 
201 & above 8 8.0 
  
 
This is the graphical representation of severity of levels of urea in our 
patients.. Majority of them had urea levels between 101-150. 
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TABLE.7   SERUM CREATININE LEVELS 
 
 
 
 
 
 
Almost 50% of the individuals had creatinine levels between 2-4 
mg/dl. 
 
 
 
Serum creatinine 
( mg/dl) 
No.of patients 
(n=100) 
Percentage 
(%) 
Less than 2 25 25.0 
2 to 4 48 48.0 
4 & above 27 27.0 
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TABLE.8   URINE SODIUM LEVELS 
 
 
 
 
 
 
Based on urine sodium levels 27% of individuals come under pre renal 
failure . 
 
URINE SODIUM LEVELS
0
5
10
15
20
25
30
35
40
45
Less than 20 21 to 40 41 & above
NO OF PTS
 
 
 
URINE Na levels 
No.of patients 
(n=100) 
Percentage 
(%) 
Less than 20 27 27.0 
21 to 40 39 39.0 
41 & above 34 34.0 
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TABLE.9  SERUM POTASSIUM LEVELS 
 
 
 
 
 
 
Only 8% in our AKI population had hyperkalemia . 
POTASSIUM meq/l No.of patients 
Percentage 
(%) 
Less than 4.5 46 46.0 
4.5 to 5.5 46 46.0 
5.5 & above 8 8.0 
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TABLE.10  GLOMERULAR FILTERATION RATE LEVELS 
 
 
  
 
 
 
           
 
Severity of renal failure based on gfr values are calculated and plotted 
in the above chart.  
Almost 60% had gfr  less than 30ml/min . 
GFR ml/min 
NO OF PATIENTS 
(n=100) 
Percentage 
(%) 
Less than 15 24 24.0 
16 to 29 35 35.0 
30 to 59 39 39.0 
60 & above 2 2.0 
 86 
 
TABLE.11   TREATMENT MODALITIES 
 
This Chart Shows Percentage of Various Mode of Treatment In Acute 
Kidney Injury. 
 
 
 
Treatment 
No.of patients 
(n=100) 
Percentage 
(%) 
CONSERVATIVE 45 45.0 
PERITONEAL 
DIALYSIS 
30 30.0 
 
HAEMODIALYSIS 
 
26 26.0 
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TABLE.12   OUTCOME 
 
 
               
 
 
 
 
 
Almost 70% of our study population  had complete recovery as 
evidenced by the creatinine values.but 16 % of them died. 
 
 
 
Outcome 
No.of patients 
(n=100) 
Percentage 
(%) 
Death 16 16.0 
Full recovery 68 68.0 
Partial recovery 16 16.0 
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TABLE.13   COMAPARISON OF UREA LEVELS WITH OUTCOME 
           
The above table indicates there is association between urea levels with 
outcome, hence the calculated value is less than table value  (p<.0.05). 
 
 
             
 
 
 Death 
 
Complete 
recovery 
 
Partial 
recovery 
 
Total 
 
 
Less than 100 1(6.3%) 31(45.6%) 5(31.3%) 37 
(37%) 
X
2
=17.693 
Df=6 
.007<0.05 
Significant 
101 to 150 4(25%) 22(32.4%) 8(50%) 34 
(34%) 
151 to 200 8(50%) 11(16.2%) 2(12.5%) 21 
(21%) 
201 & above 3(18.8%) 4(5.9%) 1(6.3%) 8  
(8%) 
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TABLE.14   COMARISON OF SERUM CREATININE LEVELS 
WITH OUTCOME 
 
SERUM 
CREATININE 
OUTCOME 
Statistical 
inference Death 
 
Complete 
recovery 
Partial 
recovery 
Total 
 
Less than 2 0 25(36.8%) 0 
25 
(25%) 
X
2
=62.980 Df=4 
.000<0.05 
Significant 
2 to 4 0 38(55.9%) 10(62.5%) 
48 
(48%) 
4 & above 16(100%) 5(7.4%) 6(37.5%) 
27 
(27%) 
 
This  table  represents  that there is  associciation between creatinine  
and recovery status in our patients which is shown by statistically significant 
values. 
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TABLE.15    COMPARISON OF UREA LEVELS WITH   
       CONSERVATIVE TREATMENT 
 
Above table indicates that there is no association between urea and 
conservative treatment.hence the calculated values are greater than the table 
values where as the creatinine values correlated with the conservative line of 
treatment. 
TABLE.16   COMPARISON OF SERUM CREATININE LEVELS 
WITH CONSERVATIVE TREATMENT 
SERUM 
CREATININE 
CONSERVATIVE 
TREATMENT 
Statistical inference 
ABSENT 
 
PRESENT 
Total 
Less than 2 2(3.6%) 23(51.1%) 
25 
(25%) 
X
2
=35.411 Df=2 
.000<0.05 
Significant 
2 to 4 29(52.7%) 19(42.2%) 
48 
(48%) 
4 & above 24(43.6%) 3(6.7%) 
27 
(27%) 
 
 
 
Urea 
CONSERVATIVE TREATMENT 
Statistical inference 
ABSENT PRESENT Total 
Less than 100 20(36.4%) 17(37.8%) 37(37%) 
X
2
=1.689 Df=3 
.639>0.05 
Not Significant 
101 to 150 17(30.9%) 17(37.8%) 34(34%) 
151 to 200 12(21.8%) 9(20%) 21(21%) 
201 & above 6(10.9%) 2(4.4%) 8 (8%) 
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TABLE.17  COMPARISON OF UREA LEVELS WITH PERITONEAL 
DIALYSIS 
 
In compared with  haemodialysis   peritoneal dialysis does not show 
any correlation with elevated urea levels,where as elevated creatinine values 
correlates with peritoneal dialysis.  
 
TABLE.18   COMAPARISON OF SERUM CRATININE WITH 
PERITONEAL DIALYSIS 
 
UREA 
PERITONEAL DIALYSIS 
Statistical inference 
Done Not done Total 
Less than 100 16(53.3%) 21(30%) 37(37%) 
X
2
=5.711 Df=3 
.127>0.05 
Not Significant  
101 to 150 7(23.3%) 27(38.6%) 34(34%) 
151 to 200 6(20%) 15(21.4%) 21(21%) 
201 & above 1(3.3%) 7(10%) 8 (8%) 
SERUM 
CREATININE 
PERITONEAL DIALYSIS 
Statistical 
inference Done 
(n=30) 
Not done 
(n=70) 
Total 
(100%) 
Less than 2 2(6.7%) 23(32.9%) 
25 
(25%) 
X
2
=14.794 Df=2 
.001<0.05 
Significant 
2 to 4 23(76.7%) 25(35.7%) 
48 
(48%) 
4 & above 5(16.7%) 22(31.4%) 
27 
(27%) 
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TABLE.19   COMPARISON OF UREA LEVELS WITH 
HAEMODIALYSIS 
 
 
TABLE.20   COMPARISON OF SERUM CREATININE WITH 
HAEMODIALYSIS 
 
Above said tables indicate that there is a significant  association in 
response to elevated urea,creatinine levels to haemodialysis as depicted by 
chi square test. 
 
 
UREA 
HAEMODIALYSIS 
Statistical 
inference Not done 
 
Done 
 
Total 
(100%) 
Less than 100 33(44.6%) 4(15.4%) 37 (37%) 
X
2
=9.937 Df=3 
.019<0.05 
Significant  
101 to 150 25(33.8%) 9(34.6%) 34 (34%) 
151 to 200 12(16.2%) 9(34.6%) 21 (21%) 
201 & above 4(5.4%) 4(15.4%) 8 (8%) 
SERUM 
CREATININE 
HAEMODIALYSIS Statistical 
inference Not done 
 
Done 
 
Total 
 
Less than 2 25(33.8%) 0 25 (25%) 
X
2
=52.464 
Df=2 
.000<0.05 
Significant 
2 to 4 43(58.1%) 5(19.2%) 48 (48%) 
4 & above 6(8.1%) 21(80.8%) 27 (27%) 
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TABLE.21  COMAPARISON OF CONSERVATIVE TREATMENT 
WITH OUTCOME 
  
TABLE.22  COMAPARISON OF PERITONEAL DIALYSIS WITH 
OUTCOME 
 
The above tables illustrates that there is significant corelation  between 
consevative treatment &peritoneal dialysis with outcome. 
 
 
CONSERVATIVE 
TREATMENT 
OUTCOME 
Statistical 
inference Death 
 
Full 
recovery 
 
Partial 
recovery 
 
Total 
 
No 14(87.5%) 25(36.8%) 16(100%) 
55 
(55%) 
X
2
=29.055 
Df=2 
.000<0.05 
Significant Yes 2(12.5%) 43(63.2%) 0 
45 
(45%) 
PERITONEAL 
DIALYSIS 
OUTCOME 
Statistical 
inference Death 
 
Full 
recovery 
 
Partial 
recovery 
 
Total 
 
Done 1(6.3%) 20(29.4%) 9(56.3%) 
30 
(30%) 
X
2
=9.559 
Df=2 
.008<0.05 
Significant 
Not done 15(93.8%) 48(70.6%) 7(43.8%) 
70 
(70%) 
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TABLE.23  COMPARISON OF HAEMODIALYSIS WITH 
OUTCOME 
 
The above table illustrates there is significant corelation between 
haemodialysis and outcome p <.0.05. 
 
 
 
 
 
HAEMODIALYSIS 
OUTCOME 
Statistical 
inference Death 
 
Full 
recovery 
 
Partial 
recovery 
 
Total 
 
Not done 1(6.3%) 63(92.6%) 10(62.5%) 
74 
(74%) 
X
2
=51.560 
Df=2 
.000<0.05 
Significant 
Done 15(93.8%) 5(7.4%) 6(37.3%) 
26 
(26%) 
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TABLE.24  COMPARISON OF RECOVERY BASED ON TYPE OF 
RENAL FAILURE  
 
Both complete recovery and death is comparitively more in renal 
failure (intrinsic) as represented in the graph and table. 
 
 
 
 
TYPE OF 
RENAL 
FAILURE 
OUTCOME 
Statistical 
inference Death 
 
Complete 
recovery 
 
Partial 
recovery 
 
Total 
 
Post Renal 1(6.3%) 5(7.4%) 5(31.3%) 
11 
(11%) X
2
=20.349 
Df=4 
.019<0.05 
Significant 
Pre Renal 1(6.3%) 27(39.7%) 0 
28 
(28%) 
Renal 14(87.5%) 36(52.9%) 11(68.8%) 
61 
(61%) 
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DISCUSSION 
 
The present study is to determine the etiologies, characteristics and 
outcomes of acute kidney injury patients admitted to thanjavur medical 
college hospital from april 2013 to October 2013. 
Demographic variation : Out of 100 patients included in the study 56 were 
males and 44 were females with a mean age of 42.6 years resulting  in male 
:female ratio of 1:4 which is quite similar to 1.8:1 ratio of other developing  
countries .The M:F ratio in developed countries were 1:1. 
Kandoth 
(70)
 showed that 67% of male & 23%of female patients are brought 
to the hospitals within 24 hours of oliguria. In our study youngest age of 13 
years and oldest age of 80 years. 
Berniech B et al.,
(61)
 in which 58% were males &36%were females with 
mean age of 56.2 years. 
Ravindra L. Mehta et al., in her study 59%males &41% were males with 
mean of 59.5years,in our study mean age was less compared to other two 
studies. 
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CLINICAL FEAUTURES: 
A study of common signs & symptoms were made out.  we noticed 
that oliguria and vomiting are most common presenting symptoms 
comprising of 69% and  28% respectively .the incidence of loose stools ( 
28%), jaundice (13%) &fever (5%) were noticed. 
This findings  is compared with other studies done by Singhal AS et 
al., which showed that oliguria and vomiting was seen in 85.2% and 80% of 
patients respectively, 
Liano Fet al ., 
(63)
 in her study found that hypotension was seen in 
32.8% of patients . 52% of patients had hypotension in Bernieh et al study., 
and 20.6% of patients had hypotension in a study done by Singhal AS. In our 
study hypotension was seen in 12% of patients. 
 
 
Study series Males in % Females in % Mean age group 
Present study 56% 44% 42.6 
Bernieh B et al 58% 42% 56.2 
Ravindra L et al 59% 41% 59.5 
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Signs 
&symptoms 
Present study Singhal AS 
et al 
(62)
 
Bernieh B et 
al 
Liano F et al 
Oliguria 68% 80.0% 78% 80% 
Vomiting 28% 85.2% 80% 86% 
Loose stools 28% - - - 
Oedema 13% - 20% - 
Jaundice 13% 20% - - 
Hypotension 12% 20.6% 52% 32.8% 
 
CAUSES : 
In our present study of 100 patients of AKI, about 28 patients had AKI 
due to prerenal cause ,most commonly acute gastroenteritis out of which 27 
patients underwent conservative treatment with  I.V fluids & other 
supportive measures.One patient underwent haemodialysis, 27 patients 
recovered completely and one patients died with a mortality of 6.3%.this was 
compared with study done by Liano F et al., which has shown prerenal AKI  
was seen in 21% of patients. 
In the present study 61% of patients had AKI due to renal cause due to 
snake bite this is because the study was conducted in snake prevalent zone, 
other common etiologies are  septicemia ( 11%), acute glomerulonephritis 
(10%), poison (8%), fever (5%),  MODS(4%) ,drug induced (3%) 
respectively. 
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Etiology 
Present 
study % 
Singhal AS 
et al % 
Bernieh et al 
% 
AGE 28 12 9 
BITE 20 20 - 
SEPTICEMIA 11 12 58 
POISON 8 - - 
FEVER 5 - - 
MODS 4 - - 
DRUG INDUCED 3 3 12 
GLOMERULONEPHRITIS 10 - - 
 
In the present study, 11% due to post renal cause  out of which 5 
patients  had complete recovery & 5 patients had partial recovery and one 
patient died. 
OUTCOME: 
The course of stay in hospital and outcome of these patients with acute 
kidney injury is variable. 
In the present study out of 100 patients, 84 patients survived and about 
16 patients expired. Among the survived 68 patients had complete recovery 
&16 patients had recovered partially. Most common cause of mortality are 
renal cause of AKI ,of this septicemia   &MODS are predominant. 
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Out of 100 patients, 45 patients were treated conservatively ; 30 
patients underwent peritoneal dialysis & 26 patients underwent 
haemodialysis. 
There are about 28 patients with blood urea of more than 150mg/dl , 
out of  which 11 patients had been treated conservatively and 17 patients 
with dialysis of  which 12 died. There are about 27 patients with serum 
creatinine more than 4 meq/l , 3 patients had been treated conservatively ,24 
patients with dialysis of which 16 died. 
The overall mortality had been increase in patients with blood urea 
more than150mg/dl & serum creatinine more than 4meq/l. 
Guerin et al., in his study found that  incidence of AKI in hospitalized 
patients  with serum creatinine more than 3.4meq/dl was 7.7% and need for 
renal replacement therapy is more. Overall hospital mortality due to AKI 
was 60% and 81% in patients developed AKI within one week of admission 
to ICU. 
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CONCLUSION 
The present prospective observational study from thanjavur medical 
college ,thanjavur between april 2103 to October 2013 . 
1. The clinical features were studied; it was observed that oliguria, 
vomiting are  predominant symptoms in acute kidney injury. 
2. Snake bite  and acute diarrheal disease  were the most common cause of 
AKI , however septicemia, MODS, poisoning, drugs were the other 
AKI cause. Leptospiral AKI was on the decline. 
3. In snake bite, the ASV therapy time, bite to renal insufficiency time and 
coagulation abnormalities were the major prognostic factors predicting 
the final outcomes. 
4. The mortality was 16 % with AKI admitted and 16 % of patients who 
survived had partial recovery at discharge, overall 55 % of  patients  
required renal replacement therapy. 
We observed that early diagnosis and early intervention are 
responsible for good survival rate in AKI. 
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PROFORMA 
 
Name:                  SI. NO: 
Age:          D.O.A: 
Sex:          D.O.D: 
Occupation:         I.P. NO: 
Address: 
Presenting Complaints: 
1. History: 
Oliguria Yes No Vomiting/ 
nausea 
Yes no 
Polyuria Yes No Anorexia Yes No 
Oedema Yes No Rashes Yes No 
Dyspnea Yes No Pruritus Yes No 
Cough Yes No Jaundice Yes No 
Weight loss Yes No Fatigue Yes No 
Loose stools Yes No Haematuria Yes No 
 nephrotoxic drugs  Yes No Haemetemesis Yes No 
Native treatment Yes No Haemoptysis Yes No 
Snake/ kathandu bite Yes No Previous 
surgeries 
Yes No 
 
2. Past History: 
3. Family History: 
4. Present medications: 
5. Personal History: 
Diet/ Appetite:                                                      Bowel/ Bladder habits:                                                                                    
Drug allergy: 
6. Obstetric History (if significant): 
7. General Physical Examination: 
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Consciousness                                                                                
     Built                                                                                                   
Nutrition                                                                                            
Pallor / Icterus / Cyanosis / Skin rash                                                                                            
Signs of dehydration / JVP                                                                                                     
Pedal   Oedema  / Lymph nodes  / Conjunctival suffusion                                                                     
Fundus                                                                                                         
Other findings 
Pulse rate:                                                           Blood pressure:                                                                                                                                                                                                                                                                                                        
Respiratory rate:                                                  Temperature:                                                                                     
Weight:                                                                Height:                                                                                                 
Peripheral Pulses 
8. Systemic Examination: 
   ABDOMEN: 
  RESPIRATORY SYSTEM: 
      CARDIOVASCULAR SYSTEM: 
 CENTRAL NERVOUS SYSTEM: 
9. CLINICAL DIAGNOSIS: 
10. INVESTIGATIONS: 
  
  
  
   
 
 
BLOOD: 
FBS:      CBC: 
PPBS: 
 
Date    
B.UREA(mg%)    
S.CREATININE(mg%)    
S.SODIUM( meq/l)    
S.POTASSIUM 
(meq/l) 
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               URINE SODIUM: URINE ROUTINE: 
ECG –  
CHEST X RAY -  
USG Abdomen –          
      Right kidney -        mm*        mm. Echo-                  CMD-                      
      Left kidney  -         mm*        mm.Echo-                   CMD-                      
               IMP: 
SPECIAL INVESTIGATIONS (when indicated): 
   ANA / ds DNA      
  Anti GBM antibody    
   Rheumatoid Factor   
   Urine BJ protein     
    Serum EPP 
11. TREATMENT GIVEN:                                                                                                                                                           
      Conservative treatment : IVF /  Antibiotics 
Peritoneal Dialysis:    
Haemodialysi:s 
12. PATTERN OF RECOVERY: 
Partial recovery / full recovery / renal biopsy 
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KEY TO  MASTER CHART 
 
 
M – Male 
F - Female 
WBCT – Whole Blood Clotting Time 
PLT- Platelet Count 
P- PRESENT 
A-ABSENT 
D- DONE 
N-NOT DONE 
F- Full Recovery 
P-Partial Recovery 
PD-Peritoneal Dialysis 
HD- Hemodialysis 
LFT- Liver Function Test. 
CULTURE-Blood Culture 
MP- Smear For Malarial Parasite 
BT-Bleeding Time 
CT-Clotting Time 
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1 1467514 69 M A A A p P A P A A 126 4.8 13 139 4.9 46 WBCT,PLT renal snake bite 0 N p D
2 1467472 60 M A A A p p A A P A 125 3.8 18 149 4.2 51 renal drug induced 0 D N F
3 1467595 50 M A A A p P A P A A 142 4.3 16 136 5.1 60 WBCT,PLT renal snake bite 0 N p F
4 1468726 35 M A P p A A A A A A 224 2.4 33 150 4.8 14 pre-renal AGE 0 N N F
5 1469929 60 M A A A A A A A A A 158 3.8 18 137 5.2 47 usg abd postrenal BPH 0 D N F
6 1471079 55 M A A A A A A A A A 108 2.8 26 151 4.8 36 usg abd postrenal BOO 0 D N p
7 1471106 40 M p A p p A A A A A 160 4.4 16 138 5.2 38 culture renal septicemia 0 N p p
8 1482385 44 M A A A A A A A P A 96 3.5 21 131 4 49 renal drug induced 0 D N F
9 1443604 40 F A A A A p A A A A 75 4.9 11 152 5.4 56 culture renal septicemia 0 N p D
10 1447556 50 F A A A A P A P A A 132 5.2 13 139 5.1 48 WBCT,PLT renal snake bite 1 N N F
11 1451466 50 F A P A A A A A A A 142 1.9 30 145 4.3 21 pre-renal AGE 1 N N F
12 1460236 60 F A A A A A A P A A 65 2.1 26 137 4.6 28 WBCT,PLT renal snake bite 1 N N F
13 1462632 65 F A A A p A A A A A 204 4.9 10 144 5.8 35 usg abd postrenal ca cervix 0 N p p
14 1474702 57 F A A A A A A P A A 174 5.9 8 136 4.9 29 WBCT,PLT renal snake bite 0 D N F
15 1474760 33 F A P p A A A A A A 215 2.2 28 137 3.8 18 pre-renal AGE 1 N N F
16 1455784 35 M A A A p A A A A A 158 5.8 12 124 6.2 86 culture renal septicemia 0 N p D
17 1476060 60 F A A A p A A A P A 68 2.3 23 139 4.6 36 renal drug induced 1 N N F
18 1411358 45 F p A A p A A A A A 148 5.2 10 134 4.8 42 usg abd postrenal ca cervix 0 D N p
19 1412569 18 M A P A A A A A A 198 2.3 45 124 4.1 19 pre-renal AGE 1 D N F
20 1411939 35 F A P A A A A A A A 298 3.9 14 129 5.2 14 pre-renal AGE 0 D N F
21 1412884 16 M A A A A A A A A A 68 2.2 43 136 4.6 29 biopsy renal PSGN 0 D N p
22 1414766 17 F A A A A A A A A A 95 3.5 19 138 4.9 32 biopsy renal PSGN 0 D N F
23 1417298 32 F A P A A A A A A A 185 1.9 33 142 4.5 18 pre-renal AGE 1 N N F
24 1420973 24 M p A A A A A A A A 136 4.8 16 139 5.8 36 biopsy renal RPGN 0 N p D
25 1422462 17 M A A A A A A A A A 64 2.1 45 138 4.3 26 biopsy renal PSGN 1 N N F
26 1425073 19 M A P A A A A A A A 186 2.8 32 141 4.9 15 pre-renal AGE 1 N N F
27 1427679 45 F p A p p A A A A A 182 6.9 7 139 5.2 39 culture renal septicemia 0 N p D
28 1427577 42 F A A A p P A P A A 61 1.9 32 138 4.8 32 WBCT,PLT renal snake bite 1 N N F
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29 1429298 33 M A A p p P A A A A 132 4.8 15 124 5.3 39 LFT,ABG renal mods 0 N p D
30 1428935 12 M A P A A A A A A A 108 1.6 66 136 4.1 16 pre-renal AGE 1 N N F
31 1430366 50 F A A p p p A A A A 132 4.6 11 129 3.6 39 culture renal septicemia 0 N p p
32 1430238 40 F A A A A A A A A A 152 5.2 12 112 3.1 42 LFT,ABG renal mods 0 N p D
33 1430324 70 M A A A A A A P A A 64 2.2 32 139 3.8 45 renal kathandu 1 N N F
34 1435301 18 M A A A p p A A A P 62 2.4 37 142 4.4 28 mp,lepto renal malaria 1 N N F
35 1437953 22 M A P A A A A A A A 101 2.1 37 135 4.6 18 pre-renal AGE 1 N N F
36 1441343 14 F A A A A A A P A A 68 1.9 39 142 3.9 36 WBCT,PLT renal snake bite 1 N N F
37 1442043 40 F A A p p p A A A A 157 5.8 9 108 2.1 104 LFT,ABG renal mods 1 N p D
38 1442165 33 M A A A A A A A A A 132 4.4 17 145 5.2 53 biopsy renal RPGN 0 N p F
39 1443749 13 M A P A A A A A A A 194 2.1 47 138 4.6 14 pre-renal AGE 1 N N F
40 1445364 56 F A A A A A A P A A 53 1.7 34 135 4.1 49 WBCT,PLT renal snake bite 1 N N F
41 1446661 37 F p A A A A A A A A 92 2.9 20 141 3.6 39 biopsy renal RPGN 0 D N p
42 1447724 34 M A A A A A A P A A 96 3.6 21 139 4.1 26 WBCT,PLT renal snake bite 0 N p F
43 1448164 65 F A A P A A A A A A 150 5.2 9 144 5.6 106 culture renal septicemia 0 D N p
44 1447694 38 F A A A A A A A A A 102 3.8 15 139 4.8 101 biopsy renal FSGS 0 N p p
45 1451129 23 M A A A P p A A A P 65 2.2 40 135 4.1 23 mp,lepto renal leptosp 1 N N F
46 1454277 20 F A P A A A A A A A 138 1.6 44 139 4.2 16 pre-renal AGE 1 N N F
47 1455970 68 F A A p p p A A A A 186 6.2 8 126 5.9 95 lFT,ABG renal mods 1 N p D
48 1458290 68 M A A A A A A P A A 62 1.8 41 135 4.1 32 WBCT,PLT renal snake bite 1 N N F
49 1458912 55 M A A A A A A A A A 156 3.2 22 142 4.8 37 usg abd postrenal renal calculi 0 D N F
50 1460477 34 M A P A A A A A A A 139 1.9 45 139 4.9 19 pre-renal AGE 1 N N F
51 1463208 65 F A A A A A A A A A 109 2.2 24 141 4.6 34 usg abd postrenal BPH 1 N N F
52 1457479 25 M A A A A A A P A A 72 2.8 30 138 4.1 42 WBCT,PLT renal snake bite 0 D N F
53 1481607 57 M A P A A A A A A A 101 1.1 74 135 3.9 16 pre-renal AGE 1 N N F
54 1481497 65 M A A A A A A P A A 98 3.2 21 141 4.8 46 WBCT,PLT renal snake bite 0 N p F
55 1435071 53 M A A A A A A A A A 109 2.6 28 134 4.9 52 usg abd postrenal renal calculi 0 D N F
56 1463918 60 F A P A A A A A A A 162 1.8 31 146 3.7 17 pre-renal AGE 1 N N F
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57 1472245 42 F p A A p A A A A A 154 5.3 10 134 4.8 52 culture renal septicemia 0 N p p
58 1473098 52 M A A A p A A P A A 66 2.1 36 144 4.2 32 renal bee sting 1 N N F
59 1475610 43 F A P A A A A A A A 145 1.8 33 136 3.6 13 pre-renal AGE 1 N N F
60 1476937 12 F A A A A A A A A A 74 2.2 34 145 3.8 53 biopsy renal PSGN 0 D N F
61 1476063 48 F A A A A A A A A A 97 3.2 17 139 4.9 65 biopsy renal FSGS 0 N p F
62 1475504 46 M A P A A A A A A A 176 1.9 41 138 4.8 19 pre-renal AGE 1 N N F
63 1477261 43 F p A A A A A A A A 184 6.2 8 121 5.6 41 culture renal septicemia 0 N p D
64 1476252 50 F p A A A A A A A A 185 4.2 12 146 4.9 37 usg abd postrenal ca cervix 0 D N D
65 1479495 26 M A P A A A A A A A 142 1.6 56 138 4.8 16 pre-renal AGE 1 N N F
66 1478260 31 M A P A A A A A A A 164 1.8 48 142 3.9 12 pre-renal AGE 1 N N F
67 1464299 65 F A A A A A A P A A 64 2.2 19 143 4.6 38 WBCT,PLT renal snake bite 1 N N F
68 1464262 36 M A A A p A A A A A 60 2 41 146 4.2 35 LFT,ABG renal Parquat pois 0 D N F
69 1466254 55 FF A A A A A A P A A 59 2.3 24 134 4.8 45 WBCT,PLT renal snake bite 0 D N F
70 1466258 55 F A P p A A A A A A 200 2 28 138 3.9 16 pre-renal AGE 0 D N F
71 1469800 55 M A A A A A A A A A 130 2.1 26 146 4.4 39 usg abd postrenal BPH 0 N N p
72 1470603 24 F A A A p A A A A A 180 6 10 126 5.3 42 CPK renal vasmol pois 0 N p D
73 1470644 45 M p A A p A A A A A 211 7.3 9 128 6.2 36 culture renal septicemia 0 N p D
74 1469543 42 M A A p p A A A A A 90 3 25 143 4.9 32 BT,CT,LFT renal ratol poison 0 D N p
75 1472694 48 F A A A A A A P A A 88 2.8 20 137 4.4 56 WBCT,PLT renal snake bite 1 N N F
76 1471731 55 M A P A A A A A A A 222 2.3 32 142 3.8 16 pre-renal AGE 1 N N F
77 1473979 12 M A P A A A A A A A 150 1.8 58 139 3.4 20 pre-renal AGE 1 N N F
78 147438 18 M A A A A A A A A A 80 2.6 35 138 4.1 65 biopsy renal PSGN 0 D N p
79 1479275 35 F A P A A A A A A A 120 1.9 32 143 4.9 17 pre-renal AGE 1 N N F
80 1481520 15 M p A A p p A A A P 92 3.6 25 145 4.3 39 mp,lepto renal malaria 0 D N F
81 1483222 33 M A P A A A A A A A 146 1.8 47 128 5.1 14 pre-renal AGE 1 N N F
82 1468233 22 M A A A A A A P A A 84 2.6 33 139 3.4 29 WBCT,PLT renal snake bite 1 N N F
83 1469565 46 M A A A A A A A A A 111 3.7 19 143 5.5 64 renal Parquat pois 0 N p p
84 1468004 65 M A P A A A A A A A 123 1.9 39 136 3.9 15 pre-renal AGE 1 N N F
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85 1469896 60 F p A A p A A A A A 104 2.1 26 142 3.5 39 usg abd postrenal ca cervix,RT 0 D N p
86 1467387 60 F A P A A A A A A A 111 1.8 31 141 3.6 12 pre-renal AGE 1 N N F
87 1469161 40 M A A A A A A A A A 222 7.2 10 152 5.1 42 cpk renal vasmol pois 0 N p D
88 1469862 50 M p A A p A A A A A 96 3.5 20 139 4.9 555 culture renal septicemia 0 D N p
89 1469946 58 M A P A A A A A A A 130 1.7 45 137 3.8 18 pre-renal AGE 1 N N F
90 1464738 72 M A A A A A A A A A 56 1.8 40 136 4.2 16 usg abd postrenal BPH 1 N N F
91 1470171 50 M A A A A A A P A A 92 3.1 23 152 5.4 37 WBCT,PLT renal snake bite 0 D N F
92 1468512 32 M A A A A A A A A A 89 2.6 31 139 4.6 33 renal cu so4 pois 0 D N F
93 1478963 65 M A A A A A A P A A 49 1.9 40 138 3.8 62 WBCT,PLT renal snake bite 1 N N F
94 1473698 45 F A P A A A A A A A 146 2.8 27 146 3.6 21 pre-renal AGE 1 N N F
95 1472589 26 M A A A A A A A A P 59 3.1 27 143 4.7 36 MP,lepto renal puo 0 D N F
96 1472356 12 F A A A A A A A A A 95 4.1 17 137 5.3 41 renal unknown poi 0 D N F
97 1482563 47 M p A A p A A A A A 261 8.4 8 123 5.9 54 culture renal septicemia 0 N p D
98 1472369 80 F A P p p A A A A A 149 4.6 10 135 4.1 17 pre-renal AGE 0 N p D
99 1472589 39 M A A A p A A A A A 121 3.5 21 141 3.9 37 renal cu so4 pois 0 D N F
100 1487966 62 F A A A A A A A A P 69 2.1 26 138 3.8 34 MP,lepto renal puo 1 N N F
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